Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | ABL1 | P00519 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | ELOVL6 | Q9H5J4 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 5/20 | 0.47 |
| ▸ | CA1 | P00915 | 5/20 | 0.47 |
| ▸ | CA2 | P00918 | 5/20 | 0.47 |
| ▸ | CA9 | Q16790 | 5/20 | 0.47 |
| ▸ | CA4 | P22748 | 4/20 | 0.47 |
| ▸ | CA7 | P43166 | 4/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.47 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3207477 | 0.88 | GPR119 (0.61) | L3MBTL1GPR119KDM4EABL1LMNA | |
| SCHEMBL3216395 | 0.88 | GPR119 (0.55) | L3MBTL1GPR119KDM4EABL1LMNA | |
| SCHEMBL3218002 | 0.87 | GPR119 (0.52) | L3MBTL1GPR119KDM4EABL1LMNA | |
| SCHEMBL3212925 | 0.83 | ADRB1 (0.50) | L3MBTL1KDM4EELOVL6DGAT1 | |
| SCHEMBL3213659 | 0.82 | LMNA (0.56) | L3MBTL1GPR119KDM4EABL1LMNA | |
| SCHEMBL5335588 | 0.81 | L3MBTL1 (0.91) | L3MBTL1GPR119KDM4EABL1LMNA | |
| SCHEMBL10316049 | 0.74 | GPR119 (1.00) | L3MBTL1GPR119KDM4EABL1LMNA | |
| SCHEMBL3220012 | 0.74 | HSD11B1 (0.69) | TRPV1 | |
| SCHEMBL4754464 | 0.73 | KDM4E (0.67) | L3MBTL1GPR119KDM4EABL1LMNA | |
| SCHEMBL1244712 | 0.73 | KDM4E (0.68) | L3MBTL1GPR119KDM4EABL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100029648-A1 | 11-Beta HSD1 Inhibitors | XIANG JASON SHAOYUN | 2010-02-04 | — | — | US | disclosed |
| US-7632838-B2 | 11-beta HSD1 inhibitors | WYETH (US) | 2009-12-15 | — | — | US | disclosed |
| US-20070219198-A1 | 11-Beta HSD 1 inhibitors | WYETH (US) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029648-A1 | 11-Beta HSD1 Inhibitors | HSD11B1, HSD3B1, HSD11B2 | L3MBTL1 1721/4885GPR119 626/4885KDM4E 1296/4885 |
| US-20070219198-A1 | 11-Beta HSD 1 inhibitors | HSD11B1, HSD11B2, HSD3B1 | L3MBTL1 2300/4885GPR119 600/4885KDM4E 1360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.